tranylcypromine has been researched along with Glioblastoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mielke, D; Ninkovic, M; Rohde, V; Sachkova, A; Schatlo, B; Sperling, S | 1 |
Ambrosio, S; Amente, S; Faicchia, D; Gorini, F; Lania, L; Majello, B; Matarese, G; Saccà, CD | 1 |
Barton, M; Chandra, J; Flores, ER; Johnson, B; Lang, F; Singh, MM; Su, X; Venkatarayan, A; Zhang, J | 1 |
Bielecka, AM; Obuchowicz, E | 1 |
Aldape, K; Barton, MC; Bhat, KP; Chandra, J; Manton, CA; Singh, MM; Tsai, WW | 1 |
5 other study(ies) available for tranylcypromine and Glioblastoma
Article | Year |
---|---|
Combined Applications of Repurposed Drugs and Their Detrimental Effects on Glioblastoma Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycoproteins; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Riluzole; Temozolomide; Tranylcypromine; Valproic Acid; Xenograft Model Antitumor Assays | 2019 |
Inhibition of lysine-specific demethylase LSD1 induces senescence in Glioblastoma cells through a HIF-1α-dependent pathway.
Topics: Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cellular Senescence; Enzyme Inhibitors; Glioblastoma; Histone Demethylases; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mechanistic Target of Rapamycin Complex 1; Mitochondria; Tranylcypromine | 2019 |
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Female; Glioblastoma; High-Throughput Nucleotide Sequencing; Histone Deacetylase Inhibitors; Histone Demethylases; Humans; Hydroxamic Acids; Immunoblotting; Mice; Mice, Nude; Neoplastic Stem Cells; Polymerase Chain Reaction; Transcriptome; Tranylcypromine; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays | 2015 |
Antidepressant drugs can modify cytotoxic action of temozolomide.
Topics: Antidepressive Agents; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Dacarbazine; Depression; Drug Interactions; Fluoxetine; Glioblastoma; Humans; Imipramine; Temozolomide; Tranylcypromine; Tumor Hypoxia | 2017 |
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
Topics: Acetylation; Astrocytes; Blotting, Western; Brain Neoplasms; Caspases; Cells, Cultured; DNA Methylation; Drug Synergism; Glioblastoma; Histone Deacetylase Inhibitors; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Monoamine Oxidase Inhibitors; Neoplastic Stem Cells; Neural Stem Cells; RNA, Small Interfering; Tranylcypromine; Vorinostat | 2011 |